Mark DeLegge to Non-alcoholic Fatty Liver Disease
This is a "connection" page, showing publications Mark DeLegge has written about Non-alcoholic Fatty Liver Disease.
Connection Strength
0.819
-
Recruitment and Retention of Patients for Nonalcoholic Steatohepatitis Clinical Trials. Gastroenterol Clin North Am. 2020 03; 49(1):123-140.
Score: 0.636
-
Machine learning using longitudinal prescription and medical claims for the detection of non-alcoholic steatohepatitis (NASH). BMJ Health Care Inform. 2022 Mar; 29(1).
Score: 0.183